| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ind-Swift Limited (NSE: INDSWFTLTD)
INDSWFTLTD Technical Analysis
4
| As on 25th Jan 2022 INDSWFTLTD Share Price closed @ 14.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.07 & Buy for SHORT-TERM with Stoploss of 10.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INDSWFTLTD Share Price
| Open | 14.75 | Change | Price | % |
| High | 15.20 | 1 Day | -0.75 | -4.84 |
| Low | 14.75 | 1 Week | -1.95 | -11.68 |
| Close | 14.75 | 1 Month | 1.65 | 12.60 |
| Volume | 21373 | 1 Year | 10.00 | 210.53 |
| 52 Week High 17.85 | 52 Week Low 3.55 | ||||
NSE INDIA Most Active Stocks
| IDEA | 11.30 | 3.20% |
| VISESHINFO | 1.55 | 3.33% |
| JPPOWER | 9.05 | 2.84% |
| SUZLON | 11.00 | -0.90% |
| ZOMATO | 100.45 | 9.96% |
| YESBANK | 13.60 | 1.12% |
| BANKBARODA | 98.50 | 6.37% |
| PNB | 39.40 | 3.68% |
| ALOKINDS | 29.70 | 2.77% |
| INVENTURE | 5.45 | -4.39% |
NSE INDIA Top Gainers Stocks
| SALONA | 327.00 | 20.00% |
| SHARDACROP | 525.35 | 20.00% |
| AMBICAAGAR | 34.05 | 18.85% |
| PRESSMN | 48.65 | 16.67% |
| CORALFINAC | 49.85 | 14.60% |
| TRITURBINE | 214.30 | 14.42% |
| OMAXE | 93.10 | 13.95% |
| ARMANFIN | 792.95 | 13.76% |
| ORBTEXP | 100.00 | 13.44% |
| BIL | 304.25 | 12.31% |
NSE INDIA Top Losers Stocks
| INDSWFTLTD Daily Charts |
INDSWFTLTD Intraday Charts |
Whats New @ Bazaartrend |
INDSWFTLTD Free Analysis |
|
|
INDSWFTLTD Important Levels Intraday
| RESISTANCE | 15.62 |
| RESISTANCE | 15.34 |
| RESISTANCE | 15.17 |
| RESISTANCE | 15.00 |
| SUPPORT | 14.50 |
| SUPPORT | 14.33 |
| SUPPORT | 14.16 |
| SUPPORT | 13.88 |
INDSWFTLTD Target for Month January
| 4th UP TARGET | 17.42 |
| 3rd UP TARGET | 15.91 |
| 2nd UP TARGET | 14.97 |
| 1st UP TARGET | 14.04 |
| 1st DOWN TARGET | 11.36 |
| 2nd DOWN TARGET | 10.43 |
| 3rd DOWN TARGET | 9.49 |
| 4th DOWN TARGET | 7.98 |
INDSWFTLTD Weekly Target
| 4th UP TARGET | 22.80 |
| 3rd UP TARGET | 20.70 |
| 2nd UP TARGET | 19.40 |
| 1st UP TARGET | 18.10 |
| 1st DOWN TARGET | 14.40 |
| 2nd DOWN TARGET | 13.10 |
| 3rd DOWN TARGET | 11.80 |
| 4th DOWN TARGET | 9.70 |
INDSWFTLTD Target for Year 2022
| 4th UP TARGET | 37.85 |
| 3rd UP TARGET | 29.78 |
| 2nd UP TARGET | 24.8 |
| 1st UP TARGET | 19.81 |
| 1st DOWN TARGET | 5.59 |
| 2nd DOWN TARGET | 0.6 |
| 3rd DOWN TARGET | -4.38 |
| 4th DOWN TARGET | -12.45 |
Ind-Swift Limited ( NSE INDIA Symbol : INDSWFTLTD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INDSWFTLTD Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 2.01 | |
| 10 Day Avg Volume | Traded 380.79 % More then 10 Day Average Volume | ||
INDSWFTLTD Other Details
| Segment | BE | |
| Market Capital | 670001920.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
INDSWFTLTD Address
 |
||
INDSWFTLTD Latest News
INDSWFTLTD Business Profile
Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India. Address: 781, Industrial Area, Chandigarh, India, 160002
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service